Global Bioresorbable Medical Polymer Supply, Demand and Key Producers, 2026-2032
The global Bioresorbable Medical Polymer market size is expected to reach $ 1933 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Bioresorbable Medical Polymer refers to a class of biocompatible polymer materials designed to gradually degrade and be absorbed by the human body through natural metabolic processes after fulfilling their medical function, widely used in temporary implants, drug delivery systems, wound closure devices, tissue engineering scaffolds, orthopedic fixation products, cardiovascular devices, and regenerative medicine applications to eliminate the need for secondary surgical removal procedures.
The Bioresorbable Medical Polymer industry chain includes upstream suppliers of bio-based monomers, petrochemical intermediates, catalysts, specialty additives, medical-grade chemicals, and precision polymerization equipment, while midstream manufacturers focus on polymer synthesis, purification, compounding, extrusion, molding, sterilization, material modification, and regulatory validation to produce bioresorbable medical-grade polymers and related components, and downstream sectors include medical device manufacturers, pharmaceutical companies, hospitals, research institutes, orthopedic implant producers, cardiovascular device developers, tissue engineering enterprises, and regenerative medicine providers that utilize these polymers for implants, drug delivery systems, sutures, and biodegradable medical devices, with increasing demand supported by aging populations, minimally invasive procedures, and advanced biomaterials innovation worldwide.
Current projects under construction and planning within the Bioresorbable Medical Polymer market include biodegradable cardiovascular stent manufacturing facilities, advanced orthopedic implant production plants, regenerative medicine material research centers, pharmaceutical controlled-release polymer expansion projects, tissue engineering scaffold development programs, medical-grade polymer compounding facilities, and 3D-printed bioresorbable implant commercialization initiatives across North America, Europe, China, Japan, and South Korea, where rising demand for minimally invasive and biodegradable medical technologies is accelerating investment activity, while manufacturers and biotechnology companies are simultaneously expanding GMP cleanroom infrastructure, pilot-scale polymer synthesis capabilities, clinical testing partnerships, biomaterials R&D laboratories, and strategic collaborations with hospitals, medical device companies, and academic research institutions to strengthen technological competitiveness and regulatory approval capacity.
2025 Global Market Average Gross Profit Margin: 42%.
The Bioresorbable Medical Polymer market has experienced rapid expansion due to increasing demand for advanced biomaterials, minimally invasive treatment technologies, and biodegradable medical devices. The market is transitioning from conventional permanent implant materials toward temporary bioresorbable solutions capable of degrading safely within the human body after completing therapeutic functions. Growth is strongly supported by rising global healthcare expenditures, aging populations, increasing orthopedic and cardiovascular disease prevalence, and technological advances in regenerative medicine and tissue engineering. North America remains one of the largest and most technologically advanced markets because of strong medical device innovation capabilities, extensive clinical research activity, and favorable reimbursement systems. Europe maintains significant market share due to strict medical quality standards, advanced biomaterials research, and strong pharmaceutical and medical device industries. Asia-Pacific, particularly China, Japan, and South Korea, is emerging as a major growth region supported by expanding healthcare infrastructure, government support for biotechnology innovation, and increasing domestic medical device manufacturing capabilities.
Market opportunities are closely associated with the expansion of regenerative medicine, drug delivery technologies, tissue engineering, and personalized healthcare solutions. Increasing demand for biodegradable orthopedic fixation devices, cardiovascular stents, wound closure materials, and controlled drug release systems continues to create substantial growth potential. Technological advances in nanotechnology, bioactive polymers, and 3D bioprinting are also opening new application areas for bioresorbable materials. Pharmaceutical and biotechnology companies are increasingly investing in polymer-based drug delivery systems capable of improving therapeutic efficiency and reducing side effects. However, the market also faces several risks, including high research and development costs, strict regulatory approval requirements, long clinical validation cycles, and technical challenges related to degradation control and mechanical stability. Material biocompatibility issues, sterilization sensitivity, and variability in in vivo degradation behavior may affect product performance and commercialization timelines. In addition, intellectual property barriers and the need for extensive clinical evidence may limit market entry for smaller companies.
Future trends are expected to include wider adoption of fully biodegradable cardiovascular devices, smart drug delivery polymers, tissue regeneration scaffolds, and AI-assisted biomaterials design platforms. Sustainability considerations, precision medicine development, and increasing demand for less invasive medical treatments are expected to remain the primary long-term drivers shaping the global Bioresorbable Medical Polymer market.
This report studies the global Bioresorbable Medical Polymer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bioresorbable Medical Polymer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bioresorbable Medical Polymer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bioresorbable Medical Polymer total market, 2021-2032, (USD Million)
Global Bioresorbable Medical Polymer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Bioresorbable Medical Polymer total market, key domestic companies, and share, (USD Million)
Global Bioresorbable Medical Polymer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Bioresorbable Medical Polymer total market by Type, CAGR, 2021-2032, (USD Million)
Global Bioresorbable Medical Polymer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Bioresorbable Medical Polymer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Corbion, DSM-Firmenich, Poly-Med, Ashland, For?creu, Zeus Company LLC, REVA, DuPont, BMG Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Bioresorbable Medical Polymer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Bioresorbable Medical Polymer Market, By Region:
1. How big is the global Bioresorbable Medical Polymer market?
2. What is the demand of the global Bioresorbable Medical Polymer market?
3. What is the year over year growth of the global Bioresorbable Medical Polymer market?
4. What is the total value of the global Bioresorbable Medical Polymer market?
5. Who are the Major Players in the global Bioresorbable Medical Polymer market?
6. What are the growth factors driving the market demand?
Bioresorbable Medical Polymer refers to a class of biocompatible polymer materials designed to gradually degrade and be absorbed by the human body through natural metabolic processes after fulfilling their medical function, widely used in temporary implants, drug delivery systems, wound closure devices, tissue engineering scaffolds, orthopedic fixation products, cardiovascular devices, and regenerative medicine applications to eliminate the need for secondary surgical removal procedures.
The Bioresorbable Medical Polymer industry chain includes upstream suppliers of bio-based monomers, petrochemical intermediates, catalysts, specialty additives, medical-grade chemicals, and precision polymerization equipment, while midstream manufacturers focus on polymer synthesis, purification, compounding, extrusion, molding, sterilization, material modification, and regulatory validation to produce bioresorbable medical-grade polymers and related components, and downstream sectors include medical device manufacturers, pharmaceutical companies, hospitals, research institutes, orthopedic implant producers, cardiovascular device developers, tissue engineering enterprises, and regenerative medicine providers that utilize these polymers for implants, drug delivery systems, sutures, and biodegradable medical devices, with increasing demand supported by aging populations, minimally invasive procedures, and advanced biomaterials innovation worldwide.
Current projects under construction and planning within the Bioresorbable Medical Polymer market include biodegradable cardiovascular stent manufacturing facilities, advanced orthopedic implant production plants, regenerative medicine material research centers, pharmaceutical controlled-release polymer expansion projects, tissue engineering scaffold development programs, medical-grade polymer compounding facilities, and 3D-printed bioresorbable implant commercialization initiatives across North America, Europe, China, Japan, and South Korea, where rising demand for minimally invasive and biodegradable medical technologies is accelerating investment activity, while manufacturers and biotechnology companies are simultaneously expanding GMP cleanroom infrastructure, pilot-scale polymer synthesis capabilities, clinical testing partnerships, biomaterials R&D laboratories, and strategic collaborations with hospitals, medical device companies, and academic research institutions to strengthen technological competitiveness and regulatory approval capacity.
2025 Global Market Average Gross Profit Margin: 42%.
The Bioresorbable Medical Polymer market has experienced rapid expansion due to increasing demand for advanced biomaterials, minimally invasive treatment technologies, and biodegradable medical devices. The market is transitioning from conventional permanent implant materials toward temporary bioresorbable solutions capable of degrading safely within the human body after completing therapeutic functions. Growth is strongly supported by rising global healthcare expenditures, aging populations, increasing orthopedic and cardiovascular disease prevalence, and technological advances in regenerative medicine and tissue engineering. North America remains one of the largest and most technologically advanced markets because of strong medical device innovation capabilities, extensive clinical research activity, and favorable reimbursement systems. Europe maintains significant market share due to strict medical quality standards, advanced biomaterials research, and strong pharmaceutical and medical device industries. Asia-Pacific, particularly China, Japan, and South Korea, is emerging as a major growth region supported by expanding healthcare infrastructure, government support for biotechnology innovation, and increasing domestic medical device manufacturing capabilities.
Market opportunities are closely associated with the expansion of regenerative medicine, drug delivery technologies, tissue engineering, and personalized healthcare solutions. Increasing demand for biodegradable orthopedic fixation devices, cardiovascular stents, wound closure materials, and controlled drug release systems continues to create substantial growth potential. Technological advances in nanotechnology, bioactive polymers, and 3D bioprinting are also opening new application areas for bioresorbable materials. Pharmaceutical and biotechnology companies are increasingly investing in polymer-based drug delivery systems capable of improving therapeutic efficiency and reducing side effects. However, the market also faces several risks, including high research and development costs, strict regulatory approval requirements, long clinical validation cycles, and technical challenges related to degradation control and mechanical stability. Material biocompatibility issues, sterilization sensitivity, and variability in in vivo degradation behavior may affect product performance and commercialization timelines. In addition, intellectual property barriers and the need for extensive clinical evidence may limit market entry for smaller companies.
Future trends are expected to include wider adoption of fully biodegradable cardiovascular devices, smart drug delivery polymers, tissue regeneration scaffolds, and AI-assisted biomaterials design platforms. Sustainability considerations, precision medicine development, and increasing demand for less invasive medical treatments are expected to remain the primary long-term drivers shaping the global Bioresorbable Medical Polymer market.
This report studies the global Bioresorbable Medical Polymer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Bioresorbable Medical Polymer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Bioresorbable Medical Polymer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Bioresorbable Medical Polymer total market, 2021-2032, (USD Million)
Global Bioresorbable Medical Polymer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Bioresorbable Medical Polymer total market, key domestic companies, and share, (USD Million)
Global Bioresorbable Medical Polymer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Bioresorbable Medical Polymer total market by Type, CAGR, 2021-2032, (USD Million)
Global Bioresorbable Medical Polymer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Bioresorbable Medical Polymer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Corbion, DSM-Firmenich, Poly-Med, Ashland, For?creu, Zeus Company LLC, REVA, DuPont, BMG Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Bioresorbable Medical Polymer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Bioresorbable Medical Polymer Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polycaprolactone (PCL)
- Polylactic-co-Glycolic Acid (PLGA)
- Others
- Injection Molded
- Extruded
- Others
- Synthetic Bioresorbable
- Natural Bioresorbable
- Bio-Based Bioresorbable
- Hybrid Composite Bioresorbable
- Others
- Orthopedic Implants
- Cardiovascular Stents
- Drug Delivery Systems
- Surgical Sutures
- Others
- Evonik
- Corbion
- DSM-Firmenich
- Poly-Med
- Ashland
- For?creu
- Zeus Company LLC
- REVA
- DuPont
- BMG Inc
- Geon Performance Solutions LLC
- Bezwada Biomedical LLC
- Mitsui Chemicals
1. How big is the global Bioresorbable Medical Polymer market?
2. What is the demand of the global Bioresorbable Medical Polymer market?
3. What is the year over year growth of the global Bioresorbable Medical Polymer market?
4. What is the total value of the global Bioresorbable Medical Polymer market?
5. Who are the Major Players in the global Bioresorbable Medical Polymer market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Bioresorbable Medical Polymer Introduction
1.2 World Bioresorbable Medical Polymer Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Bioresorbable Medical Polymer Total Market by Region (by Headquarter Location)
1.3.1 World Bioresorbable Medical Polymer Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.3 China Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.4 Europe Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.5 Japan Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.6 South Korea Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.7 ASEAN Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.8 India Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bioresorbable Medical Polymer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.2 World Bioresorbable Medical Polymer Consumption Value by Region
2.2.1 World Bioresorbable Medical Polymer Consumption Value by Region (2021-2026)
2.2.2 World Bioresorbable Medical Polymer Consumption Value Forecast by Region (2027-2032)
2.3 United States Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.4 China Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.5 Europe Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.6 Japan Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.7 South Korea Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.8 ASEAN Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.9 India Bioresorbable Medical Polymer Consumption Value (2021-2032)
3 WORLD BIORESORBABLE MEDICAL POLYMER COMPANIES COMPETITIVE ANALYSIS
3.1 World Bioresorbable Medical Polymer Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Bioresorbable Medical Polymer Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Bioresorbable Medical Polymer in 2025
3.2.3 Global Concentration Ratios (CR8) for Bioresorbable Medical Polymer in 2025
3.3 Bioresorbable Medical Polymer Company Evaluation Quadrant
3.4 Bioresorbable Medical Polymer Market: Overall Company Footprint Analysis
3.4.1 Bioresorbable Medical Polymer Market: Region Footprint
3.4.2 Bioresorbable Medical Polymer Market: Company Product Type Footprint
3.4.3 Bioresorbable Medical Polymer Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Bioresorbable Medical Polymer Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Bioresorbable Medical Polymer Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Bioresorbable Medical Polymer Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Bioresorbable Medical Polymer Consumption Value Comparison
4.2.1 United States VS China: Bioresorbable Medical Polymer Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Bioresorbable Medical Polymer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Bioresorbable Medical Polymer Companies and Market Share, 2021-2026
4.3.1 United States Based Bioresorbable Medical Polymer Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026)
4.4 China Based Companies Bioresorbable Medical Polymer Revenue and Market Share, 2021-2026
4.4.1 China Based Bioresorbable Medical Polymer Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026)
4.5 Rest of World Based Bioresorbable Medical Polymer Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Bioresorbable Medical Polymer Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Bioresorbable Medical Polymer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polycaprolactone (PCL)
5.2.4 Polylactic-co-Glycolic Acid (PLGA)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Bioresorbable Medical Polymer Market Size by Type (2021-2026)
5.3.2 World Bioresorbable Medical Polymer Market Size by Type (2027-2032)
5.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MANUFACTURING TECHNOLOGY TYPE
6.1 World Bioresorbable Medical Polymer Market Size Overview by Manufacturing Technology Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Technology Type
6.2.1 Injection Molded
6.2.2 Extruded
6.2.3 Others
6.3 Market Segment by Manufacturing Technology Type
6.3.1 World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2021-2026)
6.3.2 World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2027-2032)
6.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type (2027-2032)
7 MARKET ANALYSIS BY SOURCE MATERIAL TYPE
7.1 World Bioresorbable Medical Polymer Market Size Overview by Source Material Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source Material Type
7.2.1 Synthetic Bioresorbable
7.2.2 Natural Bioresorbable
7.2.3 Bio-Based Bioresorbable
7.2.4 Hybrid Composite Bioresorbable
7.2.5 Others
7.3 Market Segment by Source Material Type
7.3.1 World Bioresorbable Medical Polymer Market Size by Source Material Type (2021-2026)
7.3.2 World Bioresorbable Medical Polymer Market Size by Source Material Type (2027-2032)
7.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Bioresorbable Medical Polymer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Orthopedic Implants
8.2.2 Cardiovascular Stents
8.2.3 Drug Delivery Systems
8.2.4 Surgical Sutures
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Bioresorbable Medical Polymer Market Size by Application (2021-2026)
8.3.2 World Bioresorbable Medical Polymer Market Size by Application (2027-2032)
8.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Evonik
9.1.1 Evonik Details
9.1.2 Evonik Major Business
9.1.3 Evonik Bioresorbable Medical Polymer Product and Services
9.1.4 Evonik Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Evonik Recent Developments/Updates
9.1.6 Evonik Competitive Strengths & Weaknesses
9.2 Corbion
9.2.1 Corbion Details
9.2.2 Corbion Major Business
9.2.3 Corbion Bioresorbable Medical Polymer Product and Services
9.2.4 Corbion Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Corbion Recent Developments/Updates
9.2.6 Corbion Competitive Strengths & Weaknesses
9.3 DSM-Firmenich
9.3.1 DSM-Firmenich Details
9.3.2 DSM-Firmenich Major Business
9.3.3 DSM-Firmenich Bioresorbable Medical Polymer Product and Services
9.3.4 DSM-Firmenich Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 DSM-Firmenich Recent Developments/Updates
9.3.6 DSM-Firmenich Competitive Strengths & Weaknesses
9.4 Poly-Med
9.4.1 Poly-Med Details
9.4.2 Poly-Med Major Business
9.4.3 Poly-Med Bioresorbable Medical Polymer Product and Services
9.4.4 Poly-Med Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Poly-Med Recent Developments/Updates
9.4.6 Poly-Med Competitive Strengths & Weaknesses
9.5 Ashland
9.5.1 Ashland Details
9.5.2 Ashland Major Business
9.5.3 Ashland Bioresorbable Medical Polymer Product and Services
9.5.4 Ashland Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Ashland Recent Developments/Updates
9.5.6 Ashland Competitive Strengths & Weaknesses
9.6 For?creu
9.6.1 For?creu Details
9.6.2 For?creu Major Business
9.6.3 For?creu Bioresorbable Medical Polymer Product and Services
9.6.4 For?creu Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 For?creu Recent Developments/Updates
9.6.6 For?creu Competitive Strengths & Weaknesses
9.7 Zeus Company LLC
9.7.1 Zeus Company LLC Details
9.7.2 Zeus Company LLC Major Business
9.7.3 Zeus Company LLC Bioresorbable Medical Polymer Product and Services
9.7.4 Zeus Company LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Zeus Company LLC Recent Developments/Updates
9.7.6 Zeus Company LLC Competitive Strengths & Weaknesses
9.8 REVA
9.8.1 REVA Details
9.8.2 REVA Major Business
9.8.3 REVA Bioresorbable Medical Polymer Product and Services
9.8.4 REVA Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 REVA Recent Developments/Updates
9.8.6 REVA Competitive Strengths & Weaknesses
9.9 DuPont
9.9.1 DuPont Details
9.9.2 DuPont Major Business
9.9.3 DuPont Bioresorbable Medical Polymer Product and Services
9.9.4 DuPont Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 DuPont Recent Developments/Updates
9.9.6 DuPont Competitive Strengths & Weaknesses
9.10 BMG Inc
9.10.1 BMG Inc Details
9.10.2 BMG Inc Major Business
9.10.3 BMG Inc Bioresorbable Medical Polymer Product and Services
9.10.4 BMG Inc Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BMG Inc Recent Developments/Updates
9.10.6 BMG Inc Competitive Strengths & Weaknesses
9.11 Geon Performance Solutions LLC
9.11.1 Geon Performance Solutions LLC Details
9.11.2 Geon Performance Solutions LLC Major Business
9.11.3 Geon Performance Solutions LLC Bioresorbable Medical Polymer Product and Services
9.11.4 Geon Performance Solutions LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Geon Performance Solutions LLC Recent Developments/Updates
9.11.6 Geon Performance Solutions LLC Competitive Strengths & Weaknesses
9.12 Bezwada Biomedical LLC
9.12.1 Bezwada Biomedical LLC Details
9.12.2 Bezwada Biomedical LLC Major Business
9.12.3 Bezwada Biomedical LLC Bioresorbable Medical Polymer Product and Services
9.12.4 Bezwada Biomedical LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bezwada Biomedical LLC Recent Developments/Updates
9.12.6 Bezwada Biomedical LLC Competitive Strengths & Weaknesses
9.13 Mitsui Chemicals
9.13.1 Mitsui Chemicals Details
9.13.2 Mitsui Chemicals Major Business
9.13.3 Mitsui Chemicals Bioresorbable Medical Polymer Product and Services
9.13.4 Mitsui Chemicals Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Mitsui Chemicals Recent Developments/Updates
9.13.6 Mitsui Chemicals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Bioresorbable Medical Polymer Industry Chain
10.2 Bioresorbable Medical Polymer Upstream Analysis
10.3 Bioresorbable Medical Polymer Midstream Analysis
10.4 Bioresorbable Medical Polymer Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Bioresorbable Medical Polymer Introduction
1.2 World Bioresorbable Medical Polymer Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Bioresorbable Medical Polymer Total Market by Region (by Headquarter Location)
1.3.1 World Bioresorbable Medical Polymer Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.3 China Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.4 Europe Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.5 Japan Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.6 South Korea Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.7 ASEAN Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.3.8 India Based Company Bioresorbable Medical Polymer Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Bioresorbable Medical Polymer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.2 World Bioresorbable Medical Polymer Consumption Value by Region
2.2.1 World Bioresorbable Medical Polymer Consumption Value by Region (2021-2026)
2.2.2 World Bioresorbable Medical Polymer Consumption Value Forecast by Region (2027-2032)
2.3 United States Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.4 China Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.5 Europe Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.6 Japan Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.7 South Korea Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.8 ASEAN Bioresorbable Medical Polymer Consumption Value (2021-2032)
2.9 India Bioresorbable Medical Polymer Consumption Value (2021-2032)
3 WORLD BIORESORBABLE MEDICAL POLYMER COMPANIES COMPETITIVE ANALYSIS
3.1 World Bioresorbable Medical Polymer Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Bioresorbable Medical Polymer Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Bioresorbable Medical Polymer in 2025
3.2.3 Global Concentration Ratios (CR8) for Bioresorbable Medical Polymer in 2025
3.3 Bioresorbable Medical Polymer Company Evaluation Quadrant
3.4 Bioresorbable Medical Polymer Market: Overall Company Footprint Analysis
3.4.1 Bioresorbable Medical Polymer Market: Region Footprint
3.4.2 Bioresorbable Medical Polymer Market: Company Product Type Footprint
3.4.3 Bioresorbable Medical Polymer Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Bioresorbable Medical Polymer Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Bioresorbable Medical Polymer Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Bioresorbable Medical Polymer Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Bioresorbable Medical Polymer Consumption Value Comparison
4.2.1 United States VS China: Bioresorbable Medical Polymer Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Bioresorbable Medical Polymer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Bioresorbable Medical Polymer Companies and Market Share, 2021-2026
4.3.1 United States Based Bioresorbable Medical Polymer Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026)
4.4 China Based Companies Bioresorbable Medical Polymer Revenue and Market Share, 2021-2026
4.4.1 China Based Bioresorbable Medical Polymer Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026)
4.5 Rest of World Based Bioresorbable Medical Polymer Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Bioresorbable Medical Polymer Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Bioresorbable Medical Polymer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polycaprolactone (PCL)
5.2.4 Polylactic-co-Glycolic Acid (PLGA)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Bioresorbable Medical Polymer Market Size by Type (2021-2026)
5.3.2 World Bioresorbable Medical Polymer Market Size by Type (2027-2032)
5.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MANUFACTURING TECHNOLOGY TYPE
6.1 World Bioresorbable Medical Polymer Market Size Overview by Manufacturing Technology Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Manufacturing Technology Type
6.2.1 Injection Molded
6.2.2 Extruded
6.2.3 Others
6.3 Market Segment by Manufacturing Technology Type
6.3.1 World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2021-2026)
6.3.2 World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2027-2032)
6.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type (2027-2032)
7 MARKET ANALYSIS BY SOURCE MATERIAL TYPE
7.1 World Bioresorbable Medical Polymer Market Size Overview by Source Material Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source Material Type
7.2.1 Synthetic Bioresorbable
7.2.2 Natural Bioresorbable
7.2.3 Bio-Based Bioresorbable
7.2.4 Hybrid Composite Bioresorbable
7.2.5 Others
7.3 Market Segment by Source Material Type
7.3.1 World Bioresorbable Medical Polymer Market Size by Source Material Type (2021-2026)
7.3.2 World Bioresorbable Medical Polymer Market Size by Source Material Type (2027-2032)
7.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Bioresorbable Medical Polymer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Orthopedic Implants
8.2.2 Cardiovascular Stents
8.2.3 Drug Delivery Systems
8.2.4 Surgical Sutures
8.2.5 Others
8.3 Market Segment by Application
8.3.1 World Bioresorbable Medical Polymer Market Size by Application (2021-2026)
8.3.2 World Bioresorbable Medical Polymer Market Size by Application (2027-2032)
8.3.3 World Bioresorbable Medical Polymer Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Evonik
9.1.1 Evonik Details
9.1.2 Evonik Major Business
9.1.3 Evonik Bioresorbable Medical Polymer Product and Services
9.1.4 Evonik Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Evonik Recent Developments/Updates
9.1.6 Evonik Competitive Strengths & Weaknesses
9.2 Corbion
9.2.1 Corbion Details
9.2.2 Corbion Major Business
9.2.3 Corbion Bioresorbable Medical Polymer Product and Services
9.2.4 Corbion Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Corbion Recent Developments/Updates
9.2.6 Corbion Competitive Strengths & Weaknesses
9.3 DSM-Firmenich
9.3.1 DSM-Firmenich Details
9.3.2 DSM-Firmenich Major Business
9.3.3 DSM-Firmenich Bioresorbable Medical Polymer Product and Services
9.3.4 DSM-Firmenich Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 DSM-Firmenich Recent Developments/Updates
9.3.6 DSM-Firmenich Competitive Strengths & Weaknesses
9.4 Poly-Med
9.4.1 Poly-Med Details
9.4.2 Poly-Med Major Business
9.4.3 Poly-Med Bioresorbable Medical Polymer Product and Services
9.4.4 Poly-Med Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Poly-Med Recent Developments/Updates
9.4.6 Poly-Med Competitive Strengths & Weaknesses
9.5 Ashland
9.5.1 Ashland Details
9.5.2 Ashland Major Business
9.5.3 Ashland Bioresorbable Medical Polymer Product and Services
9.5.4 Ashland Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Ashland Recent Developments/Updates
9.5.6 Ashland Competitive Strengths & Weaknesses
9.6 For?creu
9.6.1 For?creu Details
9.6.2 For?creu Major Business
9.6.3 For?creu Bioresorbable Medical Polymer Product and Services
9.6.4 For?creu Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 For?creu Recent Developments/Updates
9.6.6 For?creu Competitive Strengths & Weaknesses
9.7 Zeus Company LLC
9.7.1 Zeus Company LLC Details
9.7.2 Zeus Company LLC Major Business
9.7.3 Zeus Company LLC Bioresorbable Medical Polymer Product and Services
9.7.4 Zeus Company LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Zeus Company LLC Recent Developments/Updates
9.7.6 Zeus Company LLC Competitive Strengths & Weaknesses
9.8 REVA
9.8.1 REVA Details
9.8.2 REVA Major Business
9.8.3 REVA Bioresorbable Medical Polymer Product and Services
9.8.4 REVA Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 REVA Recent Developments/Updates
9.8.6 REVA Competitive Strengths & Weaknesses
9.9 DuPont
9.9.1 DuPont Details
9.9.2 DuPont Major Business
9.9.3 DuPont Bioresorbable Medical Polymer Product and Services
9.9.4 DuPont Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 DuPont Recent Developments/Updates
9.9.6 DuPont Competitive Strengths & Weaknesses
9.10 BMG Inc
9.10.1 BMG Inc Details
9.10.2 BMG Inc Major Business
9.10.3 BMG Inc Bioresorbable Medical Polymer Product and Services
9.10.4 BMG Inc Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 BMG Inc Recent Developments/Updates
9.10.6 BMG Inc Competitive Strengths & Weaknesses
9.11 Geon Performance Solutions LLC
9.11.1 Geon Performance Solutions LLC Details
9.11.2 Geon Performance Solutions LLC Major Business
9.11.3 Geon Performance Solutions LLC Bioresorbable Medical Polymer Product and Services
9.11.4 Geon Performance Solutions LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Geon Performance Solutions LLC Recent Developments/Updates
9.11.6 Geon Performance Solutions LLC Competitive Strengths & Weaknesses
9.12 Bezwada Biomedical LLC
9.12.1 Bezwada Biomedical LLC Details
9.12.2 Bezwada Biomedical LLC Major Business
9.12.3 Bezwada Biomedical LLC Bioresorbable Medical Polymer Product and Services
9.12.4 Bezwada Biomedical LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Bezwada Biomedical LLC Recent Developments/Updates
9.12.6 Bezwada Biomedical LLC Competitive Strengths & Weaknesses
9.13 Mitsui Chemicals
9.13.1 Mitsui Chemicals Details
9.13.2 Mitsui Chemicals Major Business
9.13.3 Mitsui Chemicals Bioresorbable Medical Polymer Product and Services
9.13.4 Mitsui Chemicals Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Mitsui Chemicals Recent Developments/Updates
9.13.6 Mitsui Chemicals Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Bioresorbable Medical Polymer Industry Chain
10.2 Bioresorbable Medical Polymer Upstream Analysis
10.3 Bioresorbable Medical Polymer Midstream Analysis
10.4 Bioresorbable Medical Polymer Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Bioresorbable Medical Polymer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Bioresorbable Medical Polymer Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Bioresorbable Medical Polymer Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Bioresorbable Medical Polymer Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Bioresorbable Medical Polymer Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Bioresorbable Medical Polymer Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Bioresorbable Medical Polymer Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Bioresorbable Medical Polymer Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Bioresorbable Medical Polymer Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Bioresorbable Medical Polymer Players in 2025
Table 12. World Bioresorbable Medical Polymer Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Bioresorbable Medical Polymer Company Evaluation Quadrant
Table 14. Head Office of Key Bioresorbable Medical Polymer Players
Table 15. Bioresorbable Medical Polymer Market: Company Product Type Footprint
Table 16. Bioresorbable Medical Polymer Market: Company Product Application Footprint
Table 17. Bioresorbable Medical Polymer Mergers & Acquisitions Activity
Table 18. United States VS China Bioresorbable Medical Polymer Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Bioresorbable Medical Polymer Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Bioresorbable Medical Polymer Companies, Headquarters (States, Country)
Table 21. United States Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 23. China Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
Table 24. China Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 26. Rest of World Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Bioresorbable Medical Polymer Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 29. World Bioresorbable Medical Polymer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Bioresorbable Medical Polymer Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Bioresorbable Medical Polymer Market Size by Type (2027-2032) & (USD Million)
Table 32. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Bioresorbable Medical Polymer Market Size Value by Manufacturing Technology Type (2021-2026) & (USD Million)
Table 34. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2027-2032) & (USD Million)
Table 35. World Bioresorbable Medical Polymer Market Size by Source Material Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Bioresorbable Medical Polymer Market Size Value by Source Material Type (2021-2026) & (USD Million)
Table 37. World Bioresorbable Medical Polymer Market Size by Source Material Type (2027-2032) & (USD Million)
Table 38. World Bioresorbable Medical Polymer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Bioresorbable Medical Polymer Market Size by Application (2021-2026) & (USD Million)
Table 40. World Bioresorbable Medical Polymer Market Size by Application (2027-2032) & (USD Million)
Table 41. Evonik Basic Information, Manufacturing Base and Competitors
Table 42. Evonik Major Business
Table 43. Evonik Bioresorbable Medical Polymer Product and Services
Table 44. Evonik Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Evonik Recent Developments/Updates
Table 46. Evonik Competitive Strengths & Weaknesses
Table 47. Corbion Basic Information, Manufacturing Base and Competitors
Table 48. Corbion Major Business
Table 49. Corbion Bioresorbable Medical Polymer Product and Services
Table 50. Corbion Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Corbion Recent Developments/Updates
Table 52. Corbion Competitive Strengths & Weaknesses
Table 53. DSM-Firmenich Basic Information, Manufacturing Base and Competitors
Table 54. DSM-Firmenich Major Business
Table 55. DSM-Firmenich Bioresorbable Medical Polymer Product and Services
Table 56. DSM-Firmenich Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. DSM-Firmenich Recent Developments/Updates
Table 58. DSM-Firmenich Competitive Strengths & Weaknesses
Table 59. Poly-Med Basic Information, Manufacturing Base and Competitors
Table 60. Poly-Med Major Business
Table 61. Poly-Med Bioresorbable Medical Polymer Product and Services
Table 62. Poly-Med Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Poly-Med Recent Developments/Updates
Table 64. Poly-Med Competitive Strengths & Weaknesses
Table 65. Ashland Basic Information, Manufacturing Base and Competitors
Table 66. Ashland Major Business
Table 67. Ashland Bioresorbable Medical Polymer Product and Services
Table 68. Ashland Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Ashland Recent Developments/Updates
Table 70. Ashland Competitive Strengths & Weaknesses
Table 71. For?creu Basic Information, Manufacturing Base and Competitors
Table 72. For?creu Major Business
Table 73. For?creu Bioresorbable Medical Polymer Product and Services
Table 74. For?creu Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. For?creu Recent Developments/Updates
Table 76. For?creu Competitive Strengths & Weaknesses
Table 77. Zeus Company LLC Basic Information, Manufacturing Base and Competitors
Table 78. Zeus Company LLC Major Business
Table 79. Zeus Company LLC Bioresorbable Medical Polymer Product and Services
Table 80. Zeus Company LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Zeus Company LLC Recent Developments/Updates
Table 82. Zeus Company LLC Competitive Strengths & Weaknesses
Table 83. REVA Basic Information, Manufacturing Base and Competitors
Table 84. REVA Major Business
Table 85. REVA Bioresorbable Medical Polymer Product and Services
Table 86. REVA Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. REVA Recent Developments/Updates
Table 88. REVA Competitive Strengths & Weaknesses
Table 89. DuPont Basic Information, Manufacturing Base and Competitors
Table 90. DuPont Major Business
Table 91. DuPont Bioresorbable Medical Polymer Product and Services
Table 92. DuPont Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. DuPont Recent Developments/Updates
Table 94. DuPont Competitive Strengths & Weaknesses
Table 95. BMG Inc Basic Information, Manufacturing Base and Competitors
Table 96. BMG Inc Major Business
Table 97. BMG Inc Bioresorbable Medical Polymer Product and Services
Table 98. BMG Inc Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BMG Inc Recent Developments/Updates
Table 100. BMG Inc Competitive Strengths & Weaknesses
Table 101. Geon Performance Solutions LLC Basic Information, Manufacturing Base and Competitors
Table 102. Geon Performance Solutions LLC Major Business
Table 103. Geon Performance Solutions LLC Bioresorbable Medical Polymer Product and Services
Table 104. Geon Performance Solutions LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Geon Performance Solutions LLC Recent Developments/Updates
Table 106. Geon Performance Solutions LLC Competitive Strengths & Weaknesses
Table 107. Bezwada Biomedical LLC Basic Information, Manufacturing Base and Competitors
Table 108. Bezwada Biomedical LLC Major Business
Table 109. Bezwada Biomedical LLC Bioresorbable Medical Polymer Product and Services
Table 110. Bezwada Biomedical LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bezwada Biomedical LLC Recent Developments/Updates
Table 112. Bezwada Biomedical LLC Competitive Strengths & Weaknesses
Table 113. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 114. Mitsui Chemicals Major Business
Table 115. Mitsui Chemicals Bioresorbable Medical Polymer Product and Services
Table 116. Mitsui Chemicals Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Mitsui Chemicals Recent Developments/Updates
Table 118. Mitsui Chemicals Competitive Strengths & Weaknesses
Table 119. Global Key Players of Bioresorbable Medical Polymer Upstream (Raw Materials)
Table 120. Global Bioresorbable Medical Polymer Typical Customers
Table 1. World Bioresorbable Medical Polymer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Bioresorbable Medical Polymer Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Bioresorbable Medical Polymer Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Bioresorbable Medical Polymer Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Bioresorbable Medical Polymer Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Bioresorbable Medical Polymer Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Bioresorbable Medical Polymer Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Bioresorbable Medical Polymer Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Bioresorbable Medical Polymer Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Bioresorbable Medical Polymer Players in 2025
Table 12. World Bioresorbable Medical Polymer Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Bioresorbable Medical Polymer Company Evaluation Quadrant
Table 14. Head Office of Key Bioresorbable Medical Polymer Players
Table 15. Bioresorbable Medical Polymer Market: Company Product Type Footprint
Table 16. Bioresorbable Medical Polymer Market: Company Product Application Footprint
Table 17. Bioresorbable Medical Polymer Mergers & Acquisitions Activity
Table 18. United States VS China Bioresorbable Medical Polymer Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Bioresorbable Medical Polymer Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Bioresorbable Medical Polymer Companies, Headquarters (States, Country)
Table 21. United States Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 23. China Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
Table 24. China Based Companies Bioresorbable Medical Polymer Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 26. Rest of World Based Bioresorbable Medical Polymer Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Bioresorbable Medical Polymer Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Bioresorbable Medical Polymer Revenue Market Share (2021-2026)
Table 29. World Bioresorbable Medical Polymer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Bioresorbable Medical Polymer Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Bioresorbable Medical Polymer Market Size by Type (2027-2032) & (USD Million)
Table 32. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Bioresorbable Medical Polymer Market Size Value by Manufacturing Technology Type (2021-2026) & (USD Million)
Table 34. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type (2027-2032) & (USD Million)
Table 35. World Bioresorbable Medical Polymer Market Size by Source Material Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Bioresorbable Medical Polymer Market Size Value by Source Material Type (2021-2026) & (USD Million)
Table 37. World Bioresorbable Medical Polymer Market Size by Source Material Type (2027-2032) & (USD Million)
Table 38. World Bioresorbable Medical Polymer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Bioresorbable Medical Polymer Market Size by Application (2021-2026) & (USD Million)
Table 40. World Bioresorbable Medical Polymer Market Size by Application (2027-2032) & (USD Million)
Table 41. Evonik Basic Information, Manufacturing Base and Competitors
Table 42. Evonik Major Business
Table 43. Evonik Bioresorbable Medical Polymer Product and Services
Table 44. Evonik Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Evonik Recent Developments/Updates
Table 46. Evonik Competitive Strengths & Weaknesses
Table 47. Corbion Basic Information, Manufacturing Base and Competitors
Table 48. Corbion Major Business
Table 49. Corbion Bioresorbable Medical Polymer Product and Services
Table 50. Corbion Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Corbion Recent Developments/Updates
Table 52. Corbion Competitive Strengths & Weaknesses
Table 53. DSM-Firmenich Basic Information, Manufacturing Base and Competitors
Table 54. DSM-Firmenich Major Business
Table 55. DSM-Firmenich Bioresorbable Medical Polymer Product and Services
Table 56. DSM-Firmenich Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. DSM-Firmenich Recent Developments/Updates
Table 58. DSM-Firmenich Competitive Strengths & Weaknesses
Table 59. Poly-Med Basic Information, Manufacturing Base and Competitors
Table 60. Poly-Med Major Business
Table 61. Poly-Med Bioresorbable Medical Polymer Product and Services
Table 62. Poly-Med Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Poly-Med Recent Developments/Updates
Table 64. Poly-Med Competitive Strengths & Weaknesses
Table 65. Ashland Basic Information, Manufacturing Base and Competitors
Table 66. Ashland Major Business
Table 67. Ashland Bioresorbable Medical Polymer Product and Services
Table 68. Ashland Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Ashland Recent Developments/Updates
Table 70. Ashland Competitive Strengths & Weaknesses
Table 71. For?creu Basic Information, Manufacturing Base and Competitors
Table 72. For?creu Major Business
Table 73. For?creu Bioresorbable Medical Polymer Product and Services
Table 74. For?creu Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. For?creu Recent Developments/Updates
Table 76. For?creu Competitive Strengths & Weaknesses
Table 77. Zeus Company LLC Basic Information, Manufacturing Base and Competitors
Table 78. Zeus Company LLC Major Business
Table 79. Zeus Company LLC Bioresorbable Medical Polymer Product and Services
Table 80. Zeus Company LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Zeus Company LLC Recent Developments/Updates
Table 82. Zeus Company LLC Competitive Strengths & Weaknesses
Table 83. REVA Basic Information, Manufacturing Base and Competitors
Table 84. REVA Major Business
Table 85. REVA Bioresorbable Medical Polymer Product and Services
Table 86. REVA Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. REVA Recent Developments/Updates
Table 88. REVA Competitive Strengths & Weaknesses
Table 89. DuPont Basic Information, Manufacturing Base and Competitors
Table 90. DuPont Major Business
Table 91. DuPont Bioresorbable Medical Polymer Product and Services
Table 92. DuPont Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. DuPont Recent Developments/Updates
Table 94. DuPont Competitive Strengths & Weaknesses
Table 95. BMG Inc Basic Information, Manufacturing Base and Competitors
Table 96. BMG Inc Major Business
Table 97. BMG Inc Bioresorbable Medical Polymer Product and Services
Table 98. BMG Inc Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. BMG Inc Recent Developments/Updates
Table 100. BMG Inc Competitive Strengths & Weaknesses
Table 101. Geon Performance Solutions LLC Basic Information, Manufacturing Base and Competitors
Table 102. Geon Performance Solutions LLC Major Business
Table 103. Geon Performance Solutions LLC Bioresorbable Medical Polymer Product and Services
Table 104. Geon Performance Solutions LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Geon Performance Solutions LLC Recent Developments/Updates
Table 106. Geon Performance Solutions LLC Competitive Strengths & Weaknesses
Table 107. Bezwada Biomedical LLC Basic Information, Manufacturing Base and Competitors
Table 108. Bezwada Biomedical LLC Major Business
Table 109. Bezwada Biomedical LLC Bioresorbable Medical Polymer Product and Services
Table 110. Bezwada Biomedical LLC Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Bezwada Biomedical LLC Recent Developments/Updates
Table 112. Bezwada Biomedical LLC Competitive Strengths & Weaknesses
Table 113. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 114. Mitsui Chemicals Major Business
Table 115. Mitsui Chemicals Bioresorbable Medical Polymer Product and Services
Table 116. Mitsui Chemicals Bioresorbable Medical Polymer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Mitsui Chemicals Recent Developments/Updates
Table 118. Mitsui Chemicals Competitive Strengths & Weaknesses
Table 119. Global Key Players of Bioresorbable Medical Polymer Upstream (Raw Materials)
Table 120. Global Bioresorbable Medical Polymer Typical Customers
LIST OF FIGURES
Figure 1. Bioresorbable Medical Polymer Picture
Figure 2. World Bioresorbable Medical Polymer Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Bioresorbable Medical Polymer Total Revenue (2021-2032) & (USD Million)
Figure 4. World Bioresorbable Medical Polymer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Bioresorbable Medical Polymer Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 13. Bioresorbable Medical Polymer Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 16. World Bioresorbable Medical Polymer Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 18. China Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 23. India Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Bioresorbable Medical Polymer by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Bioresorbable Medical Polymer Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Bioresorbable Medical Polymer Markets in 2025
Figure 27. United States VS China: Bioresorbable Medical Polymer Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Bioresorbable Medical Polymer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Bioresorbable Medical Polymer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Bioresorbable Medical Polymer Market Size Market Share by Type in 2025
Figure 31. Polylactic Acid (PLA)
Figure 32. Polyglycolic Acid (PGA)
Figure 33. Polycaprolactone (PCL)
Figure 34. Polylactic-co-Glycolic Acid (PLGA)
Figure 35. Others
Figure 36. World Bioresorbable Medical Polymer Market Size Market Share by Type (2021-2032)
Figure 37. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type, (USD Million), 2021 & 2025 & 2032
Figure 38. World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type in 2025
Figure 39. Injection Molded
Figure 40. Extruded
Figure 41. Others
Figure 42. World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type (2021-2032)
Figure 43. World Bioresorbable Medical Polymer Market Size by Source Material Type, (USD Million), 2021 & 2025 & 2032
Figure 44. World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type in 2025
Figure 45. Synthetic Bioresorbable
Figure 46. Natural Bioresorbable
Figure 47. Bio-Based Bioresorbable
Figure 48. Hybrid Composite Bioresorbable
Figure 49. Others
Figure 50. World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type (2021-2032)
Figure 51. World Bioresorbable Medical Polymer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Bioresorbable Medical Polymer Market Size Market Share by Application in 2025
Figure 53. Orthopedic Implants
Figure 54. Cardiovascular Stents
Figure 55. Drug Delivery Systems
Figure 56. Surgical Sutures
Figure 57. Others
Figure 58. World Bioresorbable Medical Polymer Market Size Market Share by Application (2021-2032)
Figure 59. Bioresorbable Medical Polymer Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. Bioresorbable Medical Polymer Picture
Figure 2. World Bioresorbable Medical Polymer Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Bioresorbable Medical Polymer Total Revenue (2021-2032) & (USD Million)
Figure 4. World Bioresorbable Medical Polymer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Bioresorbable Medical Polymer Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Bioresorbable Medical Polymer Revenue (2021-2032) & (USD Million)
Figure 13. Bioresorbable Medical Polymer Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 16. World Bioresorbable Medical Polymer Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 18. China Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 23. India Bioresorbable Medical Polymer Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Bioresorbable Medical Polymer by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Bioresorbable Medical Polymer Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Bioresorbable Medical Polymer Markets in 2025
Figure 27. United States VS China: Bioresorbable Medical Polymer Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Bioresorbable Medical Polymer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Bioresorbable Medical Polymer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Bioresorbable Medical Polymer Market Size Market Share by Type in 2025
Figure 31. Polylactic Acid (PLA)
Figure 32. Polyglycolic Acid (PGA)
Figure 33. Polycaprolactone (PCL)
Figure 34. Polylactic-co-Glycolic Acid (PLGA)
Figure 35. Others
Figure 36. World Bioresorbable Medical Polymer Market Size Market Share by Type (2021-2032)
Figure 37. World Bioresorbable Medical Polymer Market Size by Manufacturing Technology Type, (USD Million), 2021 & 2025 & 2032
Figure 38. World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type in 2025
Figure 39. Injection Molded
Figure 40. Extruded
Figure 41. Others
Figure 42. World Bioresorbable Medical Polymer Market Size Market Share by Manufacturing Technology Type (2021-2032)
Figure 43. World Bioresorbable Medical Polymer Market Size by Source Material Type, (USD Million), 2021 & 2025 & 2032
Figure 44. World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type in 2025
Figure 45. Synthetic Bioresorbable
Figure 46. Natural Bioresorbable
Figure 47. Bio-Based Bioresorbable
Figure 48. Hybrid Composite Bioresorbable
Figure 49. Others
Figure 50. World Bioresorbable Medical Polymer Market Size Market Share by Source Material Type (2021-2032)
Figure 51. World Bioresorbable Medical Polymer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Bioresorbable Medical Polymer Market Size Market Share by Application in 2025
Figure 53. Orthopedic Implants
Figure 54. Cardiovascular Stents
Figure 55. Drug Delivery Systems
Figure 56. Surgical Sutures
Figure 57. Others
Figure 58. World Bioresorbable Medical Polymer Market Size Market Share by Application (2021-2032)
Figure 59. Bioresorbable Medical Polymer Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
